Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Mylan Products Ltd., 20 Station Close, Potters Bar, Herts, EN6 1TL, United Kingdom
Zumenon 2mg Film-coated Tablets.
| Pharmaceutical Form |
|---|
|
Brick-red, round, biconvex, film-coated tablets imprinted with ‘379’ on one side. |
Each tablet contains 2 mg estradiol (as hemihydrate).
Excipient with known effect: each tablet contains 118.2 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Estradiol |
Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. |
| List of Excipients |
|---|
|
Tablets core: Lactose Film-coat: Hypromellose |
The tablets are packed in blister strips of 28. The blister strips are made of PVC film with covering Aluminium foil. Each carton contains 84 tablets.
Mylan Products Ltd., 20 Station Close, Potters Bar, Herts, EN6 1TL, United Kingdom
PL 46302/0053
14 May 1997 / 23 Mar 2006
| Drug | Countries | |
|---|---|---|
| ZUMENON | Australia, Netherlands, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
